Does pharmacological treatment of depression in people with a primary brain tumour bring any benefits? A Cochrane Review summary with commentary
Document Type
Article
Publication Date
1-1-2022
Abstract
BACKGROUND: Persons with primary brain tumour can suffer from depression. Depression may hinder rehabilitation intervention leading to further deterioration of patient's health and functioning. OBJECTIVE: The Cochrane Review aimed to assess the effectiveness and adverse effects of pharmacological treatment of depression in people with a primary brain tumour. METHODS: A Cochrane Review by Beevers et al. was summarized with comments. RESULTS: The reviewdid not find any eligible studies from the 2090 studies screened which included randomized controlled trials, cohort studies and case-control studies. CONCLUSIONS: There is no high-quality evidence as to whether pharmacological treatments for depression in people with primary brain tumours are either effective or harmful.
Keywords
Brain tumour, depression, medications, pharmacology
Divisions
rehab
Publication Title
Neurorehabilitation
Volume
50
Issue
4
Publisher
IOS Press
Publisher Location
NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS